Publications

HTG EdgeSeq™ Reveal Immunophenotyping Signatures

HTG EdgeSeq™ Reveal Immunophenotyping Signatures

Download pdf 2.1MB

Development and Verification of the HTG EdgeSeq Reveal Immune, Stroma and TME Signatures

Development and Verification of the HTG EdgeSeq™ Reveal Immune, Stroma and TME Signatures

Download pdf 870KB

Proof-of-Concept for a Whole Transcriptome Panel Using HTG EdgeSeq™ Technology

Proof-of-Concept for a Whole Transcriptome Panel Using HTG EdgeSeq™ Technology

Download pdf 192KB

HTG EdgeSeq technology offers a competitive alternative to RNA-Seq with equivalent performance and distinct advantages.

Read how the HTG EdgeSeq technology is a competitive alternative to RNA-Seq

Download pdf 613KB

Detecting clinically relevant ALK rearrangements: Comparing the HTG EdgeSeq ALKPlus Assay EU (CE-IVD)to a commercially available ALK FISH assay

Numerous mutations have been shown to drive oncogenesis in non-small cell lung cancer (NSCLC). Measuring these events with conventional methods is difficult given the small amount of material typically collected in the standard needle core biopsy or similar tissue collection method.

Download pdf 735KB

A Research Use Only Content Guide for ALK, ROS1, RET, NTRK1, HER2 and cMET Data Generated from the HTG EdgeSeq ALKPlus Assay EU

A Research Use Only Content Guide for ALK, ROS1, RET, NTRK1, HER2 and cMET Data Generated from the HTG EdgeSeq ALKPlus Assay EU

Download pdf 277KB

Detection of clinically relevant gene fusions with the HTG EdgeSeq ALKPlus Assay EU

Detection of clinically relevant gene fusions with the HTG EdgeSeq ALKPlus Assay EU

Download pdf 399KB

Post-Sequencing Quality Control Metric for the HTG EdgeSeq PATH Assay

HTG EdgeSeq PATH Assay QC white paper

Complement IHC Studies with the HTG EdgeSeq PATH Assay

HTG white paper: Complement IHC Studies with the HTG EdgeSeq PATH Assay. 2017